Evidence map›Paper›PMID 35692677›Full record

ArticleJournal of clinical biochemistry and nutrition2022

Rapid pretreatment for multi-sample analysis of advanced glycation end products and their role in nephropathy.

Sayuri Kato, Hikari Sugawa, Kodai Tabe, Kenji Ito, Hitoshi Nakashima, Ryoji Nagai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical biochemistry and nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. [Elevated advanced glycation endproducts is a risk factor for stenosis after primary arteriovenous fistula surgery].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sayuri KatoLaboratory of Food and Regulation Biology, Graduate School of Agriculture, Tokai University, 9-1-1 Toroku, Higashi-ku, Kumamoto 862-8652, Japan.
Hikari SugawaLaboratory of Food and Regulation Biology, Department of Bioscience, School of Agriculture, Tokai University, 9-1-1 Toroku, Higashi-ku, Kumamoto 862-8652, Japan.
Kodai TabeLaboratory of Food and Regulation Biology, Department of Bioscience, School of Agriculture, Tokai University, 9-1-1 Toroku, Higashi-ku, Kumamoto 862-8652, Japan.
Kenji ItoDivision of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University, 8-9-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.
Hitoshi NakashimaDivision of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University, 8-9-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.
Ryoji NagaiLaboratory of Food and Regulation Biology, Graduate School of Agriculture, Tokai University, 9-1-1 Toroku, Higashi-ku, Kumamoto 862-8652, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advanced glycation end products (AGEs), produced by the Maillard reaction between carbohydrates and proteins, may be involved in diabetes and its complications. Accurate quantification of AGEs

Indexed as

advanced glycation end productsnephropathyoxidationsolid-phase extraction

Identifiers

PMID35692677
PMCPMC9130061

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.